MedTrace Logo

National Registry of Liver First Approach

NCT04683783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2020-12-24

No results posted yet for this study

Summary

Liver metastases are present in 15-25% of patients with colorectal cancer at the time of diagnosis of the primary tumor, which is defined as synchronous liver metastases. Treatment for the potential cure of this disease includes surgical resection of both the primary tumor and liver metastases. The liver first approach was described by Mentha for patients with asymptomatic rectal tumors with with initially unresectable or borderline resectable liver metastases. There is little data in the scientific literature on how many patients scheduled for this strategy complete both surgeries and/or undergo the full chemo/radiation therapy.

Conditions

Sponsors & Collaborators

  • Spanish Association of Surgeons (AEC)

    collaborator OTHER

  • Hospital Miguel Servet

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04683783 on ClinicalTrials.gov